CoChat

Global Emergence of Resistance to Fluconazole and Voriconazole in Candida parapsilosis in Tertiary Hospitals in Spain During the C OVID-19 Pandemic

Open access
Trevijano-Contador, Nuria, Torres-Cano, Alba, Carballo-González, Cristina, Puig-Asensio, Mireia, Martín-Gómez, María Teresa, Jiménez-Martínez, Emilio, Romero, Daniel, Nuvials, Francesc Xavier, Olmos-Arenas, Roberto, Moretó-Castellsagué, María Clara, Fernández-Delgado, Lucía, Rodríguez-Sevilla, Graciela, Aguilar-Sánchez, María-Mercedes, Ayats-Ardite, Josefina, Ardanuy-Tisaire, Carmen, Sanchez-Romero, Isabel, Muñoz-Algarra, María, Merino-Amador, Paloma, González-Romo, Fernando, Megías-Lobón, Gregoria, García-Campos, Jose Angel, Mantecón-Vallejo, María Ángeles, Alcoceba, Eva, Escribano, Pilar, Guinea, Jesús, Durán-Valle, Maria Teresa, Fraile-Torres, Arturo Manuel, Roiz-Mesones, María Pía, Lara-Plaza, Isabel, de Ayala, Ana Pérez, Simón-Sacristán, María, Collazos-Blanco, Ana, Nebreda-Mayoral, Teresa, March-Roselló, Gabriel, Alcázar-Fuoli, Laura, Zaragoza, Oscar · 2022 · Open Forum Infectious Diseases

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

Background: Candida parapsilosis is a frequent cause of candidemia worldwide. Its incidence is associated with the use of medical implants, such as central venous catheters or parenteral nutrition. This species has reduced susceptibility to echinocandins, and it is susceptible to polyenes and azoles. Multiple outbreaks caused by fluconazole-nonsusceptible strains have been reported recently. A similar trend has been observed among the C. parapsilosis isolates received in the last 2 years at the Spanish Mycology Reference Laboratory. Methods: Yeast were identified by molecular biology, and antifungal susceptibility testing was performed using the European Committee on Antimicrobial Susceptibility Testing protocol. The ERG11 gene was sequenced to identify resistance mechanisms, and strain typing was carried out by microsatellite analysis. Results: We examined the susceptibility profile of 1315 C. parapsilosis isolates available at our reference laboratory between 2000 and 2021, noticing an increase in the number of isolates with acquired resistance to fluconazole, and voriconazole has increased in at least 8 different Spanish hospitals in 2020–2021. From 121 recorded clones, 3 were identified as the most prevalent in Spain (clone 10 in Catalonia and clone 96 in Castilla-Leon and Madrid, whereas clone 67 was found in 2 geographically unrelated regions, Cantabria and the Balearic Islands). Conclusions: Our data suggest that concurrently with the coronavirus disease 2019 pandemic, a selection of fluconazole-resistant C. parapsilosis isolates has occurred in Spain, and the expansion of specific clones has been noted across centers. Further research is needed to determine the factors that underlie the successful expansion of these clones and their potential genetic relatedness.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ofid/ofac605

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Geographical distribution of the different genotypes of FLC-resistant isolates. The pie charts denote the distribution of the different genotypes in different tertiary hospitals from different metropolitan areas in Spain. Abbreviation: FLC, fluconazole. Template of the map of Spain was obtained from a free repository (https://es.m.wikipedia.org/wiki/Archivo:Provinces_of_Spain_%28Blank_map%29.png) and its use and modification is allowed according to the GNU Free Documentation License, version 1.2.
Figure 1. Geographical distribution of the different genotypes of FLC-resistant isolates. The pie charts denote the distribution of the different genotypes in different tertiary hospitals from different metropolitan areas in Spain. Abbreviation: FLC, fluconazole. Template of the map of Spain was obtained from a free repository (https://es.m.wikipedia.org/wiki/Archivo:Provinces_of_Spain_%28Blank_map%29.png) and its use and modification is allowed according to the GNU Free Documentation License, version 1.2.CC BY-NC-ND · PubMed Central
Figure 2. Minimal spanning tree showing the genetic proximity of susceptible and FLC-resistant isolates from Candida parapsilosis. The numbers denote the genotype identified in each group. Straight bold lines denote groups that only differentiate in 1 marker. These groups are highlighted with the color shadows in the background. Orange: resistant strains; green: susceptible strains; blue: susceptible increased exposure (I) strains. For the origin and a description of the strains in each genotype, see Supplementary Table 1. Abbreviation: FLC, fluconazole.
Figure 2. Minimal spanning tree showing the genetic proximity of susceptible and FLC-resistant isolates from Candida parapsilosis. The numbers denote the genotype identified in each group. Straight bold lines denote groups that only differentiate in 1 marker. These groups are highlighted with the color shadows in the background. Orange: resistant strains; green: susceptible strains; blue: susceptible increased exposure (I) strains. For the origin and a description of the strains in each genotype, see Supplementary Table 1. Abbreviation: FLC, fluconazole.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 59

Metadata

Authors
Trevijano-Contador, N., Torres-Cano, A., Carballo-González, C., Puig-Asensio, M., Martín-Gómez, M. T., Jiménez-Martínez, E., Romero, D., Nuvials, F. X., Olmos-Arenas, R., Moretó-Castellsagué, M. C., Fernández-Delgado, L., Rodríguez-Sevilla, G., Aguilar-Sánchez, M.-M., Ayats-Ardite, J., Ardanuy-Tisaire, C., Sanchez-Romero, I., Muñoz-Algarra, M., Merino-Amador, P., González-Romo, F., Megías-Lobón, G., García-Campos, J. A., Mantecón-Vallejo, M. Á., Alcoceba, E., Escribano, P., Guinea, J., Durán-Valle, M. T., Fraile-Torres, A. M., Roiz-Mesones, M. P., Lara-Plaza, I., de Ayala, A. P., Simón-Sacristán, M., Collazos-Blanco, A., Nebreda-Mayoral, T., March-Roselló, G., Alcázar-Fuoli, L., & Zaragoza, O.
Affiliations
  • Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III. Carretera Majadahonda-Pozuelo , Madrid , Spain
  • Instituto de Salud Carlos III (ES)
  • Department of Infectious Diseases, Hospital Universitari de Bellvitge-Institut d´Investigació Biomèdica de Bellvitge (IDIBELL) , Barcelona , Spain
  • Universitat Autònoma de Barcelona (ES)
  • Department of Microbiology, Vall D'Hebron University Hospital, Universitat Autònoma de Barcelona , Barcelona , Spain
  • Intensive Care Unit, Vall D'Hebron University Hospital, Universitat Autònoma de Barcelona , Barcelona , Spain
  • Bellvitge University Hospital (ES)
  • Microbiology Department, Hospital Universitari de Bellvitge, IDIBELL , Barcelona , Spain
  • Microbiology Department, Hospital Universitario Puerta de Hierro , Majadahonda, Madrid , Spain
  • Microbiology Department, Hospital Universitario Clínico San Carlos , Madrid , Spain
  • Department of Clinical Microbiology, Hospital Universitario de Burgos , Burgos, Castilla y León , Spain
  • Hospital Universitario de Burgos (ES)
  • Hospital Universitario Son Espases (ES)
  • Hospital General Universitario Gregorio Marañón (ES)
  • Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
  • Microbiology and Parasitology Department, Hospital Universitario de Móstoles , Madrid , Spain
  • Microbiology Department, Marqués de Valdecilla Universitary Hospital and Instituto de Investigación Valdecilla (IDIVAL), Santander, Cantabria, Spain
  • Marqués de Valdecilla University Hospital (ES)
  • Microbiology Unit, Universitary Hospital 12 de Octubre , Madrid , Spain
  • Microbiology and Parasitology Department, Hospital Central de la Defensa Gómez Ulla , Madrid , Spain
  • Hospital Clínico Universitario de Valladolid (ES)
Venue
Open Forum Infectious Diseases
Published
2022-11-01
Volume
9
Issue
11
Pages
ofac605-ofac605
ISSN
2328-8957 (ISSN-L)
OpenAlex
W4308458455
Cited by
54
References
47
Citations by year
2026: 9 · 2025: 13 · 2024: 18 · 2023: 12 · 2022: 2
FWCI
5.50
Type
journal article
Language
en
Open access
Locations
  • Open Forum Infectious Diseases (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by-nc-nd)
  • Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by-nc-nd)
Funders
  • National Centre for Microbiology
  • Instituto de Salud Carlos III
  • Center for Biomedical Research (CB21/13/00105, CB21/13/00009, CB06/06/0037, CB06/06/0058)
  • Fondo de Investigación (MPY 117/18, MPY 305/20)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
Keywords
Candida parapsilosis, fluconazole resistance, voriconazole resistance, azole resistance, candidemia, ERG11, molecular epidemiology, COVID-19 pandemic, antifungal susceptibility, Spain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.